BD Ultra-Fine 31G x 6mm Insulin Syringe, 100’s/Box

GIVE YOUR PATIENT LESS TO FEAR WITH LESS NEEDLE, LESS PAIN, AND LESS CHANCE OF INTRAMUSCULAR INJECTION.

BD Ultra-FineTM 6mm insulin syringe is 25% shorter than the 8mm needle. This length is supported by recent recommendations published in Mayo Clinic Proceedings that advocate using the shortest needle first-line for all patient categories.1? Preferred by most patients over their current needle length, BD Ultra-FineTM 6mm insulin syringes provide an approximately 3x lower risk of intramuscular injection compared to an 8-mm needle.2,3?
The latest clinical recommendations advocate the use of shorter needle lengths for all patients with diabetes.1?Approximately 8 times lower probability of intramuscular injection compared to a12.7mm needle.2?Intramuscular injection can be painful and may lead to low blood sugar.4

Notes
* When compared to longer and thicker insulin syringe needles
? Excluding safety syringes
? Calculations assume a needle inserted at 90? without a pinch-up technique in an adult population

References

Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530.
BD 6mm Insulin Syringe Voice of Customer Market Research Report, August 2017.
Frid A, et al. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care. 1990;13(5):473-7

________________

PRODUCT FEATURES

Safe, effective and less painful
Designed to provide consistent and reliable subcutaneous delivery of insulin in the treatment of diabetes